German heart failure patients monitored on new drug dapagliflozin
NCT ID NCT06336330
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 24 times
Summary
This study tracks over 800 heart failure patients in Germany who are starting dapagliflozin, a recently approved drug. Researchers will observe how long patients stay on the medication, any side effects, and changes in symptoms and quality of life. The goal is to understand how the drug works in everyday medical practice, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Aachen, 52062, Germany
-
Research Site
Alsfeld, 36304, Germany
-
Research Site
Bamberg, 96049, Germany
-
Research Site
Bechhofen, 66894, Germany
-
Research Site
Bergisch Gladbach, 51465, Germany
-
Research Site
Berlin, 12489, Germany
-
Research Site
Berlin, 12555, Germany
-
Research Site
Brilon, 59929, Germany
-
Research Site
Bruchsal, 76646, Germany
-
Research Site
Chemnitz, 09113, Germany
-
Research Site
Dinslaken, 46535, Germany
-
Research Site
Erfurt, 99084, Germany
-
Research Site
Erfurt, 99097, Germany
-
Research Site
Essen, 45128, Germany
-
Research Site
Frankenthal, 67227, Germany
-
Research Site
Gera, 07551, Germany
-
Research Site
Hamburg, 20095, Germany
-
Research Site
Hamburg, 22087, Germany
-
Research Site
Hamburg, 22459, Germany
-
Research Site
Hoppegarten, 15366, Germany
-
Research Site
Kaiserslautern, 67655, Germany
-
Research Site
Kitzingen, 97318, Germany
-
Research Site
Ludwigsburg, 71634, Germany
-
Research Site
Ludwigshafen am Rhein, 67071, Germany
-
Research Site
M Hldorf, 84453, Germany
-
Research Site
Markkleeberg, 4416, Germany
-
Research Site
Meiningen, 98617, Germany
-
Research Site
Münster, 48149, Germany
-
Research Site
Naumburg, 6618, Germany
-
Research Site
Nuremberg, 90402, Germany
-
Research Site
Oschersleben, 39387, Germany
-
Research Site
Papenburg, 26871, Germany
-
Research Site
Pirna, 01796, Germany
-
Research Site
Potsdam, 14471, Germany
-
Research Site
Querfurt, 06268, Germany
-
Research Site
Ratingen, 40882, Germany
-
Research Site
Rostock, 18059, Germany
-
Research Site
Schleswig, 24837, Germany
-
Research Site
Schwandorf in Bayern, 92421, Germany
-
Research Site
Schwäbisch Hall, 74523, Germany
-
Research Site
Siegen, 57072, Germany
-
Research Site
Steinfurt, 48565, Germany
-
Research Site
Stollberg, 09366, Germany
-
Research Site
Straubing, 94315, Germany
-
Research Site
Stuttgart, 70178, Germany
-
Research Site
Ulm, 89073, Germany
-
Research Site
Wermsdorf, 04779, Germany
Conditions
Explore the condition pages connected to this study.